Synapse - Efsevia Vakiani

Search Within

Efsevia Vakiani

Results (90)

Clinical next generation sequencing (NGS) of esophagogastric (EG) adenocarcinomas identifies distinct molecular signatures of response to HER2 inhibition, first-line 5FU/platinum and PD1/CTLA4 blockade

Meeting Abstract

Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Tuvy, Y.; Bouvier, N.; Riches, J.; Kundra, R.; Ku, G.; Hechtman, J. F.; Kelsen, D.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save

Recurrent, truncating Sox9 mutations are associated with sox9 overexpression, KRAS mutation, and TP53 wild type status in colorectal carcinoma

Journal Article

Javier, B. M.; Yaeger, R.; Wang, L.; Sanchez-Vega, F.; Zehir, A.; Middha, S.; Sadowska, J.; Vakiani, E.; Shia, J.; Klimstra, D.; more...
Oncotarget (2016)

Fulltext@MSK | Save

Comprehensive morphological assessment of colorectal cancers characterized by The Cancer Genome Atlas (TCGA) identifies specific morphology-molecular alteration associations

Meeting Abstract

Shia, J. R.; Kuk, D.; Schultz, N.; Berger, M.; Middha, S.; Vakiani, E.; Hechtman, J.; Stadler, Z.; Weiser, M.; Gonen, M.; more...
Modern Pathology (2016)

Fulltext@MSK | Save

Comprehensive morphological assessment of colorectal cancers characterized by The Cancer Genome Atlas (TCGA) identifies specific morphology-molecular alteration associations

Meeting Abstract

Shia, J. R.; Kuk, D.; Schultz, N.; Berger, M.; Middha, S.; Vakiani, E.; Hechtman, J.; Stadler, Z.; Weiser, M.; Gonen, M.; more...
Laboratory Investigation (2016)

Fulltext@MSK | Save

Phase II trial of sorafenib in patients with chemotherapy refractory metastatic esophageal and gastroesophageal (GE) junction cancer

Journal Article

Janjigian, Y. Y.; Vakiani, E.; Ku, G. Y.; Herrera, J. M.; Tang, L. H.; Bouvier, N.; Viale, A.; Socci, N. D.; Capanu, M.; Berger, M.; more...
PLoS ONE (2015)

Fulltext@MSK | Save

Genomic profiling of esophagogastric (EG) tumors in clinical practice

Meeting Abstract

Riches, J. C.; Schultz, N.; Ku, G. Y.; Imtiaz, T.; Kelsen, D. P.; Ilson, D. H.; Solit, D. B.; Berger, M. F.; Ladanyi, M.; Arcila, M. E.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Loss of human epidermal growth factor receptor 2 (HER2) expression in HER2-overexpressing esophagogastric (EG) tumors treated with trastuzumab

Meeting Abstract

Janjigian, Y. Y.; Riches, J. C.; Ku, G. Y.; Imtiaz, T.; Capanu, M.; Chou, J. F.; Kelsen, D. P.; Ilson, D. H.; Berger, M. F.; Vakiani, E.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab refractory esophagogastric (EG) cancer

Meeting Abstract

Janjigian, Y. Y.; Ku, G. Y.; Ilson, D. H.; Boyar, M. S.; Capanu, M.; Chou, J. F.; Kelsen, D. P.; Imtiaz, T.; Berger, M. F.; Vakiani, E.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Pilot trial of combined BRAF and EGFR inhibition in BRAF-mutant metastatic colorectal cancer patients

Journal Article

Yaeger, R.; Cercek, A.; O'Reilly, E. M.; Reidy, D. L.; Kemeny, N.; Wolinsky, T.; Capanu, M.; Gollub, M. J.; Rosen, N.; Berger, M. F.; more...
Clinical Cancer Research (2015)

Fulltext@MSK | Save

RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer

Journal Article

Yaeger, R.; Cowell, E.; Chou, J. F.; Gewirtz, A. N.; Borsu, L.; Vakiani, E.; Solit, D. B.; Rosen, N.; Capanu, M.; Ladanyi, M.; more...
Cancer (2015)

Fulltext@MSK | Save